Alpha-glucosidase inhibitors for type 2 diabetes mellitus

Bias in meta-analysis detected by a simple, graphical test

1997 • 47,526 citations

A Coefficient of Agreement for Nominal Scales

1960 • 37,524 citations

Operating Characteristics of a Rank Correlation Test for Publication Bias

1994 • 15,160 citations

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

1998 • 14,996 citations

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

2002 • 10,002 citations

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1997 • 6,073 citations

Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance

1979 • 4,730 citations

Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs

2000 • 3,409 citations

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

2002 • 2,503 citations

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

2003 • 2,099 citations

Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance

2003 • 1,628 citations

A desktop guide to Type 2 diabetes mellitus

1999 • 661 citations

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

2003 • 658 citations

α-Glucosidase Inhibitors for Patients With Type 2 Diabetes

2005 • 641 citations

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1999 • 440 citations

The Efficacy of Acarbose in the Treatment of Patients with Non–Insulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial

1994 • 436 citations

Miglitol

2000 • 407 citations

Modeling Publication Selection Effects in Meta-Analysis

1992 • 356 citations

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1995 • 184 citations

Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone

1991 • 178 citations

Efficacy of 24-Week Monotherapy With Acarbose, Metformin, or Placebo in Dietary-Treated NIDDM Patients

1997 • 151 citations

Efficacy of 24-Week Monotnerapy With Acarbose, Glibenclamide, or Placebo in NIDDM Patients: The Essen Study

1994 • 149 citations

Acarbose: An α-glucosidase inhibitor

1996 • 145 citations

Effect of acarbose on insulin sensitivity in elderly patients with diabetes.

2000 • 139 citations

Reduction of Glycosylated Hemoglobin and Postprandial Hyperglycemia by Acarbose in Patients With NIDDM: A placebo-controlled dose-comparison study

1995 • 135 citations

Advantages of α-Glucosidase Inhibition as Monotherapy in Elderly Type 2 Diabetic Patients

1998 • 129 citations

Acarbose

2002 • 120 citations

The Role of Acarbose in the Treatment of Non–Insulin-Dependent Diabetes Mellitus

1998 • 119 citations

The Efficacy and Safety of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone

1997 • 114 citations

Acarbose in the treatment of elderly patients with type 2 diabetes

2002 • 106 citations

A Review of the Safety and Efficacy of Acarbose in Diabetes Mellitus

1996 • 100 citations

The Synergistic Effect of Miglitol Plus Metformin Combination Therapy in the Treatment of Type 2 Diabetes

2001 • 99 citations

A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999.

1999 • 98 citations

Miglitol: Assessment of its Role in the Treatment of Patients with Diabetes Mellitus

2000 • 96 citations

A Double-Blind Placebo-Controlled Trial Evaluating the Safety and Efficacy of Acarbose for the Treatment of Patients With Insulin-Requiring Type II Diabetes

1995 • 93 citations

Long-term Efficacy and Safety of Acarbose in the Treatment of Obese Subjects With Non—Insulin-Dependent Diabetes Mellitus

1994 • 89 citations

Effect of Acarbose on Carbohydrate and Lipid Metabolism in NIDDM Patients Poorly Controlled by Sulfonylureas

1990 • 84 citations

Acarbose: Its Role in the Treatment of Diabetes Mellitus

1996 • 84 citations

Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes

2003 • 78 citations

Long-Term Ingestion of a Fermented Soybean-Derived Touchi-Extract with α-Glucosidase Inhibitory Activity Is Safe and Effective in Humans with Borderline and Mild Type-2 Diabetes

2001 • 76 citations

Long‐term Effect of Acarbose on Glycaemic Control in Non‐insulin‐dependent Diabetes Mellitus: A Placebo‐controlled Double‐blind Study

1993 • 73 citations

Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes

1997 • 72 citations

European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses

1998 • 71 citations

Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data

2004 • 60 citations

An Asian Multicenter Clinical Trial to Assess the Efficacy and Tolerability of Acarbose Compared With Placebo in Type 2 Diabetic Patients Previously Treated With Diet

1998 • 58 citations

Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients.

2002 • 53 citations

Low-Dose Acarbose Improves Glycemic Control in NIDDM Patients Without Changes in Insulin Sensitivity

1993 • 48 citations

Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition

1998 • 48 citations

Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.

1995 • 47 citations

Comparison of Acarbose and Gliclazide as First-line Agents in Patients with Type 2 Diabetes

2001 • 43 citations

Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year study.

1999 • 42 citations

Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM

1997 • 40 citations

Effects of Dietary Treatment Alone or Diet With Voglibose or Glyburide on Abdominal Adipose Tissue and Metabolic Abnormalities in Patients With Newly Diagnosed Type 2 Diabetes

2002 • 36 citations

Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients

2003 • 35 citations

Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?

1999 • 34 citations

Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients

1998 • 33 citations

Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study.

2002 • 32 citations

Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes

2002 • 31 citations

Effects on Blood Pressure of the ??-Glucosidase Inhibitor Acarbose Compared with the Insulin Enhancer Glibenclamide in Patients with Hypertension and Type 2 Diabetes Mellitus

2002 • 31 citations

Clinical experience with acarbose: results of a Canadian multicentre study.

1995 • 29 citations

No Relationship Between Carbohydrate Intake and Effect of Acarbose on HbA1c or Gastrointestinal Symptoms in Type 2 Diabetic Subjects Consuming 30–60% of Energy From Carbohydrate

1998 • 26 citations

Acarbose for the treatment of Type II diabetes: the results of a Canadian multi-centre trial

1995 • 25 citations

Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters

2002 • 25 citations

The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.

2002 • 22 citations

Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetes

1988 • 22 citations

Miglitol, an α-glucosidase inhibitor, prevents the metformin-induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes

2000 • 20 citations

Beneficial effects on serum lipids in noninsulin dependent diabetics by acarbose treatment.

1991 • 20 citations

Is acarbose equivalent to tolbutamide as first treatment for newly diagnosed type 2 diabetes in general practice?

2003 • 17 citations

Efficacy and tolerability of miglitol in the treatment of patients with non—insulin-dependent diabetes mellitus

1995 • 16 citations

Effect of acarbose in treatment of type II diabetes mellitus: a double-blind, crossover, placebo-controlled trial.

1998 • 14 citations

Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy

2003 • 14 citations

Efficacy of 6 months monotherapy with glucosidase inhibitor Acarbose versus sulphonylurea glibenclamide on metabolic control of dietary treated type II diabetics (NIDDM).

1992 • 14 citations

Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia.

1991 • 11 citations

Multicentric clinical trial to assess efficacy and tolerability of acarbose (Bay G 5421) in comparison to glibenclamide and placebo

1997 • 11 citations

[Clinical efficacy and tolerance to acarbose in the treatment of non-insulin-dependent diabetic patients].

1993 • 5 citations

[Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].

1999 • 5 citations

Acarbose and glibenclamide in type II diabetes. A comparative study on efficacy and side effects.

1990 • 4 citations

Hypertension in type 2-diabetic patients—effects of endogenous insulin and antidiabetic therapies

2000 • 4 citations

An evalualion on efficacy of acarbose interfering trentment on IGT

2000 • 4 citations

Glucobai therapy of diabetes mellitus

1995 • 4 citations

6 months monotherapy of NIDDM with acarbose or glibenclamide

1992 • 3 citations

Acarbose Maintains Glycaemic Control in Diet Treated Type 2 Diabetes

1999 • 2 citations

Deleted Work

1955 • 0 citations